Chengyitong's revenue in 2025 amounted to 4.70 billion yuan, representing a year-on-year decrease of 50.91%. The company incurred a net loss of 8.79 billion yuan and a non-recurring net loss of 8.83 billion yuan.

In 2025, the company's revenue fell by 50.91% year-on-year to RMB 470 million, with a staggering net loss attributable to shareholders of RMB 879 million, representing an over tenfold increase in the scale of losses; the fourth quarter alone incurred a loss of RMB 947 million, far exceeding the cumulative losses for the entire year. Revenue is highly concentrated in two core businesses, with significant declines in both gross margin and net margin, while逆势 growth in sales expenses exacerbated the losses. The audit report issued a 'disclaimer of opinion,' internal control received an adverse opinion, triggering *ST and ST risk warnings, raising substantial doubts about the company’s ability to continue as a going concern.

lanjinger.comApr 30 11:33

Chengyitong: First Quarter Report for 2026

SZSIApr 30 00:00 · Announcements

Chengyitong: 2025 Annual Report

SZSIApr 30 00:00 · Announcements

Chengyitong: Summary of the 2025 Annual Report

SZSIApr 30 00:00 · Announcements

BOCI International: Three Key Technologies Drive Growth; Positive Outlook for Brain-Computer Interface Industry's Potential Expansion

Since 2026, financing activities for brain-computer interface enterprises have remained robust, with companies such as Qiangnao Technology and Jieti Medical securing substantial funding. The influx of capital is accelerating the industrialization of brain-computer interface technologies.

Zhitong FinanceApr 27 13:45

The release of national standards such as brain-computer interface marks the industry's official transition from 'planning blueprint' to 'fast track for implementation.' Institutions are optimistic about these two sectors.

① Brain-computer interfaces have officially transitioned from the technology exploration phase into clinical application, opening up commercialization opportunities in the fields of neural modulation and implantable medical devices; ② In just the first quarter of this year, the total financing amount for brain-computer interface companies has already surpassed the entire year of 2025, with industry momentum continuing to rise.

cls.cnApr 11 17:02